On a consolidated basis, the company's total income from operations was reported at Rs 115.54 crore during the quarter under review.
"During the quarter, offtake of the company's pillar brands -- Sugar Free, EverYuth and Nutralite continued to grow at a consistent pace," the company said in a statement.
"Sugar Free, India's largest selling sugar substitute, maintained its number one position with a market share of 94.6 per cent (MAT June 17 report of Nielsen), up by 50 basis points," it added.
On a closing basis, the scrips of the pharma major fell by 0.37 per cent to Rs 880.10 per share.
(This story has not been edited by Social News XYZ staff and is auto-generated from a syndicated feed.)
Doraiah Chowdary Vundavally is a Software engineer at VTech . He is the news editor of SocialNews.XYZ and Freelance writer-contributes Telugu and English Columns on Films, Politics, and Gossips. He is the primary contributor for South Cinema Section of SocialNews.XYZ. His mission is to help to develop SocialNews.XYZ into a News website that has no bias or judgement towards any.
This website uses cookies.